Results 61 to 70 of about 29,583 (248)
Should palpable DCIS be treated as IDC? A retrospective audit.
, 2011 146 Background: Ductal carcinoma in situ (DCIS) identified by screening mammography accounts for 20% of breast cancer diagnoses, and microinvasion (DCIS-M) is found in 5%-10%. There are no defined treatment guidelines for palpable DCIS or DCIS-M.
V. Vanmali +6 more
core +1 more source
IgG Glycosylation‐Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis
Arthritis &Rheumatology, EarlyView.Objective Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) that can lead to end‐stage kidney disease and increased mortality. IgG from patients with LN displays abnormal glycosylation, contributing to podocyte injury.
Rohit Upadhyay +3 more
wiley +1 more source
Chronic Diseases and Translational Medicine, 2023 Background Ductal carcinoma in situ with microinvasion (DCIS‐MI) is defined as ductal carcinoma in situ (DCIS) with a microscopic invasive focus ≤1 mm in the longest diameter.
Ge Song, Yongqiang Zhang
doaj +1 more source
, 2014 (A) Heat map of IHC markers for DCIS lesions. This heat map illustrates marker scoring for each individual DCIS lesion across six IHC markers. The individual lesions are aligned in columns and the unique patients are aligned in rows.
Mary B. Daly (196724) +8 more
core +1 more source
Neurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges
BMEMat, EarlyView.This figure illustrates various material strategies for neurovascularized bone regeneration, including electroactive scaffolds, ion‐loaded materials, drug delivery systems, surface modifications, cells/cell products, growth factors, and peptides. These approaches aim to synergistically promote the regeneration of neural, vascular, and bone tissues ...
Yixin Ma +8 more
wiley +1 more source
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? [PDF]
, 2023 Ductal carcinoma in situ (DCIS), especially in the era of mammographic screening, is a commonly diagnosed breast tumor. Despite the low breast cancer mortality risk, management with breast conserving surgery (BCS) and radiotherapy (RT) is the prevailing ...
Hahn, Ezra +13 more
core +1 more source
Biotechnology Progress, EarlyView.Abstract Haptoglobin (Hp) is a polymorphic acute phase α‐2 glycoprotein found in plasma that plays a critical role in binding, neutralizing, and removing cell‐free hemoglobin (Hb) from the circulation. Under clinical conditions characterized by high levels of hemolysis, such as in patients with sickle cell disease (SCD), large quantities of cell‐free ...
Shuwei Lu +5 more
wiley +1 more source
Psoriasin and CD24 demonstrate a similar staining pattern in DCIS.
, 2013 The expression patterns of psoriasin and CD24 in ductal carcinoma in situ (DCIS) were analyzed by immunohistochemisty. Psoriasin and CD24 showed an extremely intense staining and a similar staining pattern in DCIS.
Charlotta Enerbäck (83717) +4 more
core +1 more source
Chemistry – A European Journal, EarlyView.A set of new phosphonomethyl (thio)phosphonamidite reagents is introduced to generate unprecedented pyrophosphate mimetics. The versatile P(III)‐P(V) reagents allow for the construction of various pyrophosphate isosteres, and the applicability of the chemistry is illustrated in the assembly of a diverse set of stabilized CDP‐glycerol and CDP‐ribitol ...
Pascal Balić +4 more
wiley +1 more source
LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c
Breast Cancer Research, 2022 Background Ductal carcinoma in situ (DCIS) of breast is the noninvasive lesion that has propensity to progress to the malignant form. At present, it is still unknown which lesions can potentially progress to invasive forms.
Ravindra Pramod Deshpande +10 more
doaj +1 more source